Screening of ΔF508 mutation and IVS8‐poly T polymorphism in CFTR gene in Tunisian infertile men without CBAVD

It is well established that cystic fibrosis transmembrane conductance regulator gene (CFTR) mutations are involved in congenital bilateral absence of the vas deferens (CBAVD), causing obstructive azoospermia and male infertility. Also, several studies reported a relatively high prevalence of CFTR gene mutations in healthy men presenting reduced sperm quality. In this study, we investigate ΔF508 mutation and IVS8‐polyT polymorphism in CFTR gene in Tunisian infertile men without CBAVD. Genetic analyses were performed in 148 infertile patients and 126 fertile individuals. The polymorphic IVS8‐polyT tract in CFTR gene was analysed in only 129 infertile patients and 54 individuals of control group. As well, we screened for Y chromosome microdeletions in all infertile patients. No ΔF508 mutation was diagnosed either in infertile patients or in control group. 5T allele of IVS8‐polyT tract was found in both infertile men (4.26%) and fertile individuals (8.33%). 5T/5T genotype was observed only in two azoospermic patients without Y microdeletions. The most frequent genotype of IVS8‐polyT tract in infertile men and controls was 7T/7T (69.75% and 59.25% respectively). There was no association between IVS8‐polyT polymorphism and reduced semen quality. Neither ΔF508 mutation nor 5T allele is involved in pathogenesis of male infertility in Tunisian infertile patients without CBAVD.

[1]  X. Estivill,et al.  Heterogeneity for mutations in the CFTR gene and clinical correlations in patients with congenital absence of the vas deferens. , 2000, Human reproduction.

[2]  Z. Rosenwaks,et al.  Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. , 2003, Human reproduction.

[3]  H. Hsieh-Li,et al.  Cystic fibrosis transmembrane conductance regulator gene screening and clinical correlation in Taiwanese males with congenital bilateral absence of the vas deferens. , 2004, Human reproduction.

[4]  H. Chaabouni,et al.  Y chromosome microdeletions in Tunisian infertile males. , 2008, Pathologie-biologie.

[5]  S. Kropf,et al.  Increased frequency of cystic fibrosis transmembrane conductance regulator gene mutations in infertile males. , 2006, Fertility and sterility.

[6]  M. Montag,et al.  Combined cytogenetic and Y chromosome microdeletion screening in males undergoing intracytoplasmic sperm injection. , 1997, Molecular human reproduction.

[7]  S. Chamayou,et al.  Molecular analysis of mutations and polymorphisms in the CFTR gene in male infertility. , 2008, Reproductive biomedicine online.

[8]  G. T. te Meerman,et al.  Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracytoplasmic sperm injection. , 1998, Fertility and sterility.

[9]  T. Tarcan,et al.  Genetic diagnosis in infertile men with numerical and constitutional sperm abnormalities. , 2008, Genetic testing.

[10]  S. Rozen,et al.  Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA–binding protein gene , 1995, Nature Genetics.

[11]  P. Yen,et al.  Substantial prevalence of microdeletions of the Y-chromosome in infertile men with idiopathic azoospermia and oligozoospermia detected using a sequence-tagged site-based mapping strategy. , 1996, The Journal of clinical endocrinology and metabolism.

[12]  M. Zatz,et al.  Analysis of mutations in the cystic fibrosis transmembrane regulator (CFTR) gene in patients with obstructive azoospermia , 2003 .

[13]  C. Higgins,et al.  Tissue-specific in vivo transcription start sites of the human and murine cystic fibrosis genes. , 1998, Human molecular genetics.

[14]  L. Tsui,et al.  Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. , 1999, JAMA.

[15]  T. Dörk,et al.  Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens , 1997, Human Genetics.

[16]  M. Tzetis,et al.  Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia. , 1998, Molecular human reproduction.

[17]  R. Klingenberg,et al.  Rational approach to genetic testing of cystic fibrosis (CF) in infertile men , 2005, Andrologia.

[18]  A. Edelmann,et al.  Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. , 1996, Human molecular genetics.

[19]  H. Gourabi,et al.  Molecular analysis of the IVS8-T splice variant 5T and M470V exon 10 missense polymorphism in Iranian males with congenital bilateral absence of the vas deferens. , 2006, Molecular human reproduction.

[20]  R. Saiki,et al.  Genetic markers of male infertility: Y chromosome microdeletions and cystic fibrosis transmembrane conductance gene mutations. , 2001, Croatian medical journal.

[21]  M. Sousa,et al.  Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. , 2004, Human reproduction.

[22]  S. Gould,et al.  Expression of the cystic fibrosis gene in human foetal tissues. , 1993, Human molecular genetics.

[23]  J. Kaplan,et al.  Molecular diagnosis of congenital bilateral absence of the vas deferens: analyses of the CFTR gene in 64 French patients. , 1997, Annales de genetique.

[24]  J. Amos,et al.  The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. , 1994, Journal of andrology.

[25]  M Claustres,et al.  Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. , 1995, The New England journal of medicine.

[26]  C. Clavel,et al.  Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France , 2000, Human mutation.

[27]  B. Dastugue,et al.  Screening for cystic fibrosis transmembrane conductance regulator gene mutations in men included in an intracytoplasmic sperm injection programme. , 1999, Molecular human reproduction.

[28]  L. Lipshultz,et al.  Compound genetic abnormalities in patients with cystic fibrosis transmembrane regulator gene mutation. , 2007, Fertility and sterility.

[29]  J. L. Le Gall,et al.  Molecular screening of the CFTR gene in men with anomalies of the vas deferens: identification of three novel mutations. , 2000, Molecular human reproduction.

[30]  T. Dörk,et al.  CFTR gene mutations and male infertility , 2000, Andrologia.

[31]  M. Buchwald,et al.  Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. , 1994, The American journal of pathology.

[32]  T. Dörk,et al.  Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens. , 2004, Human reproduction.

[33]  C. Ober,et al.  Cystic fibrosis mutation screening in healthy men with reduced sperm quality. , 1996, Human reproduction.

[34]  W. Engel,et al.  Relevance of genetic counselling in couples prior to intracytoplasmic sperm injection. , 1997, Human reproduction.

[35]  C. Foresta,et al.  Y chromosome microdeletions and alterations of spermatogenesis. , 2001, Endocrine reviews.

[36]  Wan-Xiang Xu,et al.  CFTR is essential for sperm fertilizing capacity and is correlated with sperm quality in humans. , 2010, Human reproduction.

[37]  L. Tsui,et al.  Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia , 1995, The Lancet.